以开阖枢理论为指导使用柴胡调枢汤治疗2型糖尿病的研究
|
摘要
糖尿病(消渴病)是临床常见病、多发病。近年来,随着我国国民经济的快速发展,人们生活水平的不断提高,生活压力的不断加大,糖尿病的发病率逐年升高,日益受到医务工作者和普通百姓的重视。目前在控制血糖方面西药疗效较显著,但存在着副作用大、改善临床表现差的缺点,而中医药在改善糖尿病患者临床表现、提高生活质量、预防和减少并发症等方面存在着独特的优势。因此,在中医学基础理论指导下,继续研究治疗糖尿病的高效低毒的中医方药,具有重要的现实意义和临床应用价值。论文共分文献综述、理论研究和临床研究三部分。
文献综述部分,首先总结了目前中医界主流观点认糖尿病(消渴病)为阴虚燥热为主的病机认识和三消分治为主的治疗模式,进而分别从按照病位论治(包括从肝论治、从脾论治、从肾论治、从心论治、数脏腑兼治),按照病因或病理产物论治(包括从痰湿论治、从瘀论治、从痰瘀论治、从毒论治、从气论治等),其他理论和方法(例如玄府理论)等角度,论述了古今论治消渴病的理论和方法。
理论研究部分,阐释了开阖枢理论与糖尿病(消渴病)的关系。开阖枢理论起源于《黄帝内经》,其原始意义是对门户的结构及其功能的完整描述。《黄帝内经》将开阖枢从门户理论延伸扩展为阳气升降出入理论,即人体阳气在门户升降出入,其工作机制是开阖枢。人体有两扇门,一扇是三阳主宰的在表的阳门,一扇是三阴主宰的在里的阴门。每扇门都有各自的开阖枢,即三阳的阳门“太阳为开,阳明为阖,少阳为枢”;三阴的阴门“太阴为开,厥阴为阖,少阴为枢。”阳门、阴门的开、阖、枢都决定于阳气的升降出入,因为阴阳之间是阳主阴从的关系,即阳为主导,阴为随从,二者间是以阳为主导的动态平衡关系。这一理论在《伤寒杂病论》中得到了发展和具体应用。论文中论述了开、阖、枢的功能特点,即开以升发外散为主,阖以沉降内入为主,枢以协调开阖为主。开、阖、枢三者是一个完整而统一的整体,相互协调,相互为用。进而论述了开阖枢理论实质内涵和开阖枢病理状态下的临床表现。继而揭示了人体两大枢机,即少阳为阳枢,主司调节阳气在表之升降出入;少阴为阴枢,主司调节阳气在里之升降出入。少阳阳枢与少阴阴枢在生理上密切联系,相互作用,在病理状态下则相互影响。相对应地,小柴胡汤、四逆散为张仲景调节阴阳两大枢机的主方,论文中论述了两方的应用和方解,提出柴胡为“调枢圣药”的观点。继而从八个方面进行论述,糖尿病(消渴病)的发生发展与人体阳气“开阖枢”失调密切相关。导师王永炎院士根据自身长期临床、科研的结果,提出糖尿病(消渴病)的发病关键在于枢机不利。并依据糖尿病(消渴病)所处的时期不同,枢机不利有所偏重,即疾病早、中期以少阳枢机不利为主,晚期以少阴枢机不利为主。因此,治疗糖尿病(消渴病)的关键在于调理两大枢机,枢机调则三阴三阳的阳气升降出入正常。王院士的柴胡调枢汤就是以小柴胡汤、四逆散为基础,结合其临床经验而拟定,抓住了糖尿病(消渴病)的发病关键,在此基础上随症加减,枢机得调则消渴自止。
临床研究部分,观察了柴胡调枢汤治疗糖尿病的临床疗效和安全性。将患者随机分为治疗组、对照组各32例,对照组单用二甲双胍,治疗组在二甲双胍治疗的基础上加用柴胡调枢汤随症加减,治疗8周,观察治疗前后空腹血糖、餐后2小时血糖、糖化血红蛋白、中医症状及血常规、尿常规、便常规、肝功能、肾功能、心电图的变化。结果:经Ridit检验和重复测量的方差分析,治疗组对于空腹血糖、餐后2小时血糖、中医症状总积分、疾病疗效的疗效均好于对照组;而对于糖化血红蛋白的疗效,两组间差异不显著。通过综合分析,认为“柴胡调枢汤+二甲双胍”对于2型糖尿病的主、客观指标疗效均优于单纯应用二甲双胍,并且具有很好的安全性。由此可见,基于开阖枢理论创立的柴胡调枢汤治疗糖尿病具有很好的疗效和安全性,值得进一步临床推广应用。
最后得出结论:“阳主阴从”思想是包括中医在内的传统文化认识宇宙、把握万物的关键;“开阖枢”理论是传统中医解读生命、治疗疾病的重要理论;糖尿病(消渴病)核心病机是枢机不利;少阳、少阴枢机不利证的临床表现存在复杂性和双重性;柴胡调枢汤治疗糖尿病(消渴病)的关键在于调阳理枢。
本研究首次将“开阖枢”理论应用于2型糖尿病的临床研究中,突出了中国传统儒释道文化和中医注重阳气的观点。深化了中医对糖尿病病机的认识,为临床治疗糖尿病提供了新思路,提出治疗糖尿病(消渴病)的关键是“调阳理枢”,创新和丰富了糖尿病(消渴病)的病机学说和治疗学说。
Diabetes is a common and frequently occurring disease in clinic. And it can heavily influence people's work and living. In recent years, the incidence of diabetes is increasing year after year along with our country's national income enhance fleetly, resident standard of living improved constantly, the changing of people's life style, and living pressure increase continually. Average people and medical affairs operator are more and more attach importance to diabetes than before. At present, the sugar reducing medicine commonly used in clinical practice has definitely and affirmatively curative effect in controlling blood sugar. At the same time, Western medicine has its disadvantage, for instance, badly effect in improving symptom and huge side-effect. However, Traditional Chinese Medicine (abbreviation: TCM) has its own unique advantage, for example, improving diabetes sufferer symptom and enhancing their living quality, prevent and cure subsequent disease of diabetes. Therefore, the research of how to prevention and cure diabetes has become an important thing, especially in researching and exploring new medicine for diabetes under the guidance basic theory of TCM. This work has significant practical meaning and clinical application value.
There are three parts in the thesis: document reviews, theoretic research and clinical research.
Document reviews: At first, we summarized current mainstream viewpoint of TCM about diabetes's pathogenesis key at yin-deficiency and dryness-heat, its primary therapeutic model is Sanxiaofenzhi. And then we discourse upon Diabetes's deferent treatment theory and method from ancient to modern. For example, Diabetes treated according the location of disease (including Diabetes treated according the liver or spleen or kidney or heart or several organs) or Causes and pathological products (including Diabetes treated according phlegm-dampness or blood stasis or poison or Qi), and others treatment method (For instance, Diabetes treated according Xuanfu.)
Theoretic research: We explained the relation between traditional theory of "Open, Close and Axis" and diabetes. The theory of "Open, Close and Axis" originated from inner Canon of Yellow Emperor. Original concept of "Open, Close and Axis" is a kind of description to door's structure and functions. Inner Canon of Yellow Emperor developed it to the theory of Yang's ascending, descending, exiting and entering. People's Yang ascends, descends, exits and enters at body's doors, and its working mechanism is "Open, Close and Axis". Everybody have two doors, one is yang door that is at body's surface layer, another is yin door that is at body's deep level. The two doors have its own "Open, Close and Axis". Taiyang is Open, yangming is Close and shaoyang is Axis at yang door. Taiyin is Open, jueyin is Close and shaoyin is Axis at yin door. The "Open, Close and Axis"at yang door and yin door is to be decided by yang's ascending, descending, exiting and entering. It is because that yang is magistral between yin and yang. Yang is leader and yin is attendant. We discoursed that the functional characteristicof "Open, Close and Axis". Open is primary ascending and exiting. Close is primary descending and entering. Axis is the adjustor between Open and Close. "Open, Close and Axis" are uniform , integrated, interactive , compatible as a whole. The theory of "Open, Close and Axis" was developed and applied on the treatise on febrile and miscellaneous disease. We expatiate functional characteristics and the relationship among the three of "Open, Close and Axis". And then we explained the essential and its clinical manifestations of the theory of "Open, Close and Axis". Every people have two Axis. Shaoyang is Yang Axis and it responsible for Yang's ascending, descending, exiting and entering at shallow layers. Shaoyin is Yin Axis and it responsible for Yang's ascending, descending, exiting and entering at deep layer. Shaoyang and Shaoyin contacts closely and interact reciprocally in physiological effects. Shaoyang and Shaoyin influence mutual in pathological changes. In the treatise on febrile and miscellaneous disease, Xiaochaihutang is the primary prescription of Yang Axis's dysfunction, Sinisan is the primary prescription of Yin Axis's dysfunction. We expound the compositive principle and clinical applications of Xiaochaihutang and Sinisan. We bring forward a point of view: Chaihu is the best medicine of mediating Axis's functions. According to 8 sides arguments, we made a conclusions that the occurrence and deterioration of diabetes is closely related to "Open, Close and Axis" dysfunction. According to academician Wangyongyan's experiences in clinical and scientific research, his viewpoint about the key causes of diabetes is Axis's dysfunction. Along with deferent diabetes periods, Axis's dysfunction has deferent emphases. In early and metaphase period, the emphase is Shaoyang Axis's dysfunction. In late stage, the emphase is Shaoyin Axis's dysfunction. So, mediating Shaoyang Axis and Shaoyin Axis is the key of treatment. When the Axis's dysfunction is improved, the diabetes sufferer's sufferings are alleviated. Academician Wang invent the prescription of Chaihutiaoshutang. Chaihutiaoshutang is based on Xiaochaihutang and Sinisan and tie in academician Wang's clinical experiences. By the clinical applications of Chaihutiaoshutang, we found that it has great curative effect.
Clinical research: We evaluated on clinical curative effects and security of Chaihutiaoshutang for diabetes. In the research, 64 cases were allocated to treatment group (32 cases) and control group (32 cases) randomly. The treatment group were received a treatment on the base by adding or reducing drugs of Chaihutiaoshutang and metformin, the control group only received metformin. After 8 weeks, we observed the changes of fasting blood glucose, postprandial 2 hours blood glucose, glycosylated hemoglobin, blood routine examination, urine routine examination, stool routine examination, function examination of liver and kidney and Electro cardiograph, TCM symptom. By Ridit test and of the variance analysis repeated measure, we found that the effect of treatment group is better than control group's at the level of fasting blood glucose, postprandial 2 hours blood glucose, TCM syndrome, diseases efficacy. There are no deference at glycosylated hemoglobin between the treatment group and control group. By comprehensive analysis, we believe that the effect of Chaihutiaoshutang and metformin is better than metformin;s at subjective and objective symptoms of patients. There are no side-effects in the clinical research. The study indicates that Chaihutiaoshutang based on the theory of "Open, Close and Axis" is effective and secure in treating diabetes.
We made series of conclusions that the idea of Yang is leader and Yin is assistant is the key to traditional Chinese culture and TCM. The theory of "Open, Close and Axis" is the importent theory to research life and treat diseases. The key to diabetes is Axis 's dysfunction. The symptoms of Shaoyang Axis dysfunction and Shaoyin Axis dysfunction is complicated and duality. The key construction to diabetes of Chaihutiaoshutang is point to Yang and Axis.
We firstly introduced the theory of "Open, Close and Axis" into diabetes's clinical research. We emphasized the role of Yang in traditional Chinese culture and TCM. Our research deepen the understanding to pathogenesis of diabetes, offer a new pathway for clinical therapy, blazed new trails and enrich the doctrines of pathogenesis and therapy.
文献综述部分,首先总结了目前中医界主流观点认糖尿病(消渴病)为阴虚燥热为主的病机认识和三消分治为主的治疗模式,进而分别从按照病位论治(包括从肝论治、从脾论治、从肾论治、从心论治、数脏腑兼治),按照病因或病理产物论治(包括从痰湿论治、从瘀论治、从痰瘀论治、从毒论治、从气论治等),其他理论和方法(例如玄府理论)等角度,论述了古今论治消渴病的理论和方法。
理论研究部分,阐释了开阖枢理论与糖尿病(消渴病)的关系。开阖枢理论起源于《黄帝内经》,其原始意义是对门户的结构及其功能的完整描述。《黄帝内经》将开阖枢从门户理论延伸扩展为阳气升降出入理论,即人体阳气在门户升降出入,其工作机制是开阖枢。人体有两扇门,一扇是三阳主宰的在表的阳门,一扇是三阴主宰的在里的阴门。每扇门都有各自的开阖枢,即三阳的阳门“太阳为开,阳明为阖,少阳为枢”;三阴的阴门“太阴为开,厥阴为阖,少阴为枢。”阳门、阴门的开、阖、枢都决定于阳气的升降出入,因为阴阳之间是阳主阴从的关系,即阳为主导,阴为随从,二者间是以阳为主导的动态平衡关系。这一理论在《伤寒杂病论》中得到了发展和具体应用。论文中论述了开、阖、枢的功能特点,即开以升发外散为主,阖以沉降内入为主,枢以协调开阖为主。开、阖、枢三者是一个完整而统一的整体,相互协调,相互为用。进而论述了开阖枢理论实质内涵和开阖枢病理状态下的临床表现。继而揭示了人体两大枢机,即少阳为阳枢,主司调节阳气在表之升降出入;少阴为阴枢,主司调节阳气在里之升降出入。少阳阳枢与少阴阴枢在生理上密切联系,相互作用,在病理状态下则相互影响。相对应地,小柴胡汤、四逆散为张仲景调节阴阳两大枢机的主方,论文中论述了两方的应用和方解,提出柴胡为“调枢圣药”的观点。继而从八个方面进行论述,糖尿病(消渴病)的发生发展与人体阳气“开阖枢”失调密切相关。导师王永炎院士根据自身长期临床、科研的结果,提出糖尿病(消渴病)的发病关键在于枢机不利。并依据糖尿病(消渴病)所处的时期不同,枢机不利有所偏重,即疾病早、中期以少阳枢机不利为主,晚期以少阴枢机不利为主。因此,治疗糖尿病(消渴病)的关键在于调理两大枢机,枢机调则三阴三阳的阳气升降出入正常。王院士的柴胡调枢汤就是以小柴胡汤、四逆散为基础,结合其临床经验而拟定,抓住了糖尿病(消渴病)的发病关键,在此基础上随症加减,枢机得调则消渴自止。
临床研究部分,观察了柴胡调枢汤治疗糖尿病的临床疗效和安全性。将患者随机分为治疗组、对照组各32例,对照组单用二甲双胍,治疗组在二甲双胍治疗的基础上加用柴胡调枢汤随症加减,治疗8周,观察治疗前后空腹血糖、餐后2小时血糖、糖化血红蛋白、中医症状及血常规、尿常规、便常规、肝功能、肾功能、心电图的变化。结果:经Ridit检验和重复测量的方差分析,治疗组对于空腹血糖、餐后2小时血糖、中医症状总积分、疾病疗效的疗效均好于对照组;而对于糖化血红蛋白的疗效,两组间差异不显著。通过综合分析,认为“柴胡调枢汤+二甲双胍”对于2型糖尿病的主、客观指标疗效均优于单纯应用二甲双胍,并且具有很好的安全性。由此可见,基于开阖枢理论创立的柴胡调枢汤治疗糖尿病具有很好的疗效和安全性,值得进一步临床推广应用。
最后得出结论:“阳主阴从”思想是包括中医在内的传统文化认识宇宙、把握万物的关键;“开阖枢”理论是传统中医解读生命、治疗疾病的重要理论;糖尿病(消渴病)核心病机是枢机不利;少阳、少阴枢机不利证的临床表现存在复杂性和双重性;柴胡调枢汤治疗糖尿病(消渴病)的关键在于调阳理枢。
本研究首次将“开阖枢”理论应用于2型糖尿病的临床研究中,突出了中国传统儒释道文化和中医注重阳气的观点。深化了中医对糖尿病病机的认识,为临床治疗糖尿病提供了新思路,提出治疗糖尿病(消渴病)的关键是“调阳理枢”,创新和丰富了糖尿病(消渴病)的病机学说和治疗学说。
Diabetes is a common and frequently occurring disease in clinic. And it can heavily influence people's work and living. In recent years, the incidence of diabetes is increasing year after year along with our country's national income enhance fleetly, resident standard of living improved constantly, the changing of people's life style, and living pressure increase continually. Average people and medical affairs operator are more and more attach importance to diabetes than before. At present, the sugar reducing medicine commonly used in clinical practice has definitely and affirmatively curative effect in controlling blood sugar. At the same time, Western medicine has its disadvantage, for instance, badly effect in improving symptom and huge side-effect. However, Traditional Chinese Medicine (abbreviation: TCM) has its own unique advantage, for example, improving diabetes sufferer symptom and enhancing their living quality, prevent and cure subsequent disease of diabetes. Therefore, the research of how to prevention and cure diabetes has become an important thing, especially in researching and exploring new medicine for diabetes under the guidance basic theory of TCM. This work has significant practical meaning and clinical application value.
There are three parts in the thesis: document reviews, theoretic research and clinical research.
Document reviews: At first, we summarized current mainstream viewpoint of TCM about diabetes's pathogenesis key at yin-deficiency and dryness-heat, its primary therapeutic model is Sanxiaofenzhi. And then we discourse upon Diabetes's deferent treatment theory and method from ancient to modern. For example, Diabetes treated according the location of disease (including Diabetes treated according the liver or spleen or kidney or heart or several organs) or Causes and pathological products (including Diabetes treated according phlegm-dampness or blood stasis or poison or Qi), and others treatment method (For instance, Diabetes treated according Xuanfu.)
Theoretic research: We explained the relation between traditional theory of "Open, Close and Axis" and diabetes. The theory of "Open, Close and Axis" originated from inner Canon of Yellow Emperor. Original concept of "Open, Close and Axis" is a kind of description to door's structure and functions. Inner Canon of Yellow Emperor developed it to the theory of Yang's ascending, descending, exiting and entering. People's Yang ascends, descends, exits and enters at body's doors, and its working mechanism is "Open, Close and Axis". Everybody have two doors, one is yang door that is at body's surface layer, another is yin door that is at body's deep level. The two doors have its own "Open, Close and Axis". Taiyang is Open, yangming is Close and shaoyang is Axis at yang door. Taiyin is Open, jueyin is Close and shaoyin is Axis at yin door. The "Open, Close and Axis"at yang door and yin door is to be decided by yang's ascending, descending, exiting and entering. It is because that yang is magistral between yin and yang. Yang is leader and yin is attendant. We discoursed that the functional characteristicof "Open, Close and Axis". Open is primary ascending and exiting. Close is primary descending and entering. Axis is the adjustor between Open and Close. "Open, Close and Axis" are uniform , integrated, interactive , compatible as a whole. The theory of "Open, Close and Axis" was developed and applied on the treatise on febrile and miscellaneous disease. We expatiate functional characteristics and the relationship among the three of "Open, Close and Axis". And then we explained the essential and its clinical manifestations of the theory of "Open, Close and Axis". Every people have two Axis. Shaoyang is Yang Axis and it responsible for Yang's ascending, descending, exiting and entering at shallow layers. Shaoyin is Yin Axis and it responsible for Yang's ascending, descending, exiting and entering at deep layer. Shaoyang and Shaoyin contacts closely and interact reciprocally in physiological effects. Shaoyang and Shaoyin influence mutual in pathological changes. In the treatise on febrile and miscellaneous disease, Xiaochaihutang is the primary prescription of Yang Axis's dysfunction, Sinisan is the primary prescription of Yin Axis's dysfunction. We expound the compositive principle and clinical applications of Xiaochaihutang and Sinisan. We bring forward a point of view: Chaihu is the best medicine of mediating Axis's functions. According to 8 sides arguments, we made a conclusions that the occurrence and deterioration of diabetes is closely related to "Open, Close and Axis" dysfunction. According to academician Wangyongyan's experiences in clinical and scientific research, his viewpoint about the key causes of diabetes is Axis's dysfunction. Along with deferent diabetes periods, Axis's dysfunction has deferent emphases. In early and metaphase period, the emphase is Shaoyang Axis's dysfunction. In late stage, the emphase is Shaoyin Axis's dysfunction. So, mediating Shaoyang Axis and Shaoyin Axis is the key of treatment. When the Axis's dysfunction is improved, the diabetes sufferer's sufferings are alleviated. Academician Wang invent the prescription of Chaihutiaoshutang. Chaihutiaoshutang is based on Xiaochaihutang and Sinisan and tie in academician Wang's clinical experiences. By the clinical applications of Chaihutiaoshutang, we found that it has great curative effect.
Clinical research: We evaluated on clinical curative effects and security of Chaihutiaoshutang for diabetes. In the research, 64 cases were allocated to treatment group (32 cases) and control group (32 cases) randomly. The treatment group were received a treatment on the base by adding or reducing drugs of Chaihutiaoshutang and metformin, the control group only received metformin. After 8 weeks, we observed the changes of fasting blood glucose, postprandial 2 hours blood glucose, glycosylated hemoglobin, blood routine examination, urine routine examination, stool routine examination, function examination of liver and kidney and Electro cardiograph, TCM symptom. By Ridit test and of the variance analysis repeated measure, we found that the effect of treatment group is better than control group's at the level of fasting blood glucose, postprandial 2 hours blood glucose, TCM syndrome, diseases efficacy. There are no deference at glycosylated hemoglobin between the treatment group and control group. By comprehensive analysis, we believe that the effect of Chaihutiaoshutang and metformin is better than metformin;s at subjective and objective symptoms of patients. There are no side-effects in the clinical research. The study indicates that Chaihutiaoshutang based on the theory of "Open, Close and Axis" is effective and secure in treating diabetes.
We made series of conclusions that the idea of Yang is leader and Yin is assistant is the key to traditional Chinese culture and TCM. The theory of "Open, Close and Axis" is the importent theory to research life and treat diseases. The key to diabetes is Axis 's dysfunction. The symptoms of Shaoyang Axis dysfunction and Shaoyin Axis dysfunction is complicated and duality. The key construction to diabetes of Chaihutiaoshutang is point to Yang and Axis.
We firstly introduced the theory of "Open, Close and Axis" into diabetes's clinical research. We emphasized the role of Yang in traditional Chinese culture and TCM. Our research deepen the understanding to pathogenesis of diabetes, offer a new pathway for clinical therapy, blazed new trails and enrich the doctrines of pathogenesis and therapy.
引文
[01]周华蓉,钟国跃.浅析糖尿病中成药的升发[J].世界科学技术-中医药现代化.2003,5(5):18-23.
[02]李学军.应用生活质量标准评估中西医结合疗法治疗糖尿病的效应[J].中国临床康复.2006,10(15):154,155,161.
[03]胡春宇.糖尿病与消渴病关系诠释及糖尿病辨治理念的探索[D].中国中医研究院2002级博士学位论文.15-23.
[04]张亚,王旭.2型糖尿病从肝论治机理探析[J].第九次全国中医糖尿病学术大会论文汇编.2006.272-274.
[05]林丽华,陈润东.从肝论治糖尿病的理论基础[J].中医药导报.2006,12(10):1,2,9.
[06]刘振杰,林国清.2型糖尿病从肝论治浅析[J].陕西中医.2005,26(12):1399-1400.
[07]段颖,刘铜华.从肝论治糖尿病的研究进展[J].第九次全国中医糖尿病学术大会论文汇编.2006.479-483.
[08]孟景,吴敏.糖尿病从肝论治依据回顾性探讨[J].实用中医内科杂志.2006,20(6):588-589.
[09]姜生坤,马新和,乔富渠.Ⅱ型糖尿病从肝论治探讨[J].陕西中医.2002,23(5):428-430.
[10]于淼,朴春丽,南征.2型糖尿病胰岛素抵抗从毒损肝络论治的理论初探[J].上海中医药杂志.2007,41(3):18-20.
[11]高绍芳,赵克景,杜立建等.浅谈糖尿病从肝论治[J].现代中西医结合杂志.2006,15(18):2512-2513.
[12]孟景,吴敏.糖尿病从肝论治依据回顾性探讨[J].实用中医内科杂志.2006,20(6):588-589.
[13]郭翔宇,刘铜华.消渴病从肝肿肾论治[J].第十次全国中医糖尿病学术大会论文汇编.2007.334-335.
[14]张凌志.试论糖尿病脾虚湿滞证[J].北京中医药大学学报.2002,25(3):71.
[15]李江慧.糖尿病证候统计分析[J].中国医药学报.1999,14(6):70.
[16]张超,张军,韦新宇.从脾论治糖尿病的研究近况[J].河南中医.2003,23(12):85-87.
[17]张春吉,吴铁.从脾论治消渴病体会[J].第九次全国中医糖尿病学术大会论文汇编.2006.282-284.
[18]贺文广,杨竞,钟丽红.杨竞从脾论治糖尿病的经验[J].上海中医药杂志.2005,39(3):27-28.
[19]孙鑫.从脾论治糖尿病[J].第十次全国中医糖尿病学术大会论文汇编.2007.142-147.
[20]朱汀,孙寒静.冯明清教授从脾论治糖尿病经验[J].四川中医.2002,20(4):3-4.
[21]韩洪刚.潘朝曦教授从脾论治糖尿病经验[J].实用中医内科杂志.2005,19(6):512-513.
[22]李士瑾,冯志海,徐立然等.浅谈从脾论治糖尿病[J].四川中医.2003,21(8):13-15.
[23]胡梅芳.糖尿病从脾论治分析[J].安徽中医临床杂志.2003,15(4):351-352.
[24]李肇晕,曲丽卿.再论脾与消渴病[J].时珍圉医圈药.2006,17(8):1557-1558.
[25]姬厚民.消渴病(糖尿病)从肾论治的内分泌学机制初探[J].北京中医.2007,26(5):286.
[26]蒋兆定,李灿华.糖尿病从心论治初探[J].辽宁中医学院学报.2004,6(2):98.
[27]蔡小平,周宜强,朱艳琴.糖尿病证治新理论--“脾弱胃强”观[J].中国中医基础医学杂志.2003,9(5):25-26.
[28]刘振杰,熊莉华,范冠杰.浅谈糖尿病从脾胃论治[J].新中医.2006,38(8):84-85.
[29]刘自力,吴兆利.从肝脾论治糖尿病[J].中医药信息.2005,22(6):31-34.
[30]刘振杰.糖尿病从肝脾胃论治浅析[J].江西中医药.2006,37(8):12-13.
[31]侯茗.从肺、脾(胃)、肾论治消渴病[J].中国社区中师.2007,9(2):53.
[32]接传红,陈晨,罗旭昇等.从心肾论治糖尿病视网膜病变[J].第十次全国中医糖尿病学术大会论文汇编.2007.427-428.
[33]米丰涛.从脾肾两虚论治老年性糖尿病32例[J].黑龙江中医药.2006,(2):31-23.
[34]安淑华.从脾肾论治老年性糖尿病的机理及疗效观察[J].河北北方学院学报(医学版).2007,24(4):59-60.
[35]高思华.以中西医结合理论为指导,立足肝脾肾辨治糖尿病[J].中国中西医结合杂志.1994,14(10):622-623.
[36]刘晓平.糖尿病从五脏辨治[J].中医药学刊.2005,23(10):1906-1907.
[37]王幸栓,欧晓燃,杜杏坤.五脏通治法联合胰岛素治疗初诊2型糖尿病的可行性探讨[J].中医药学刊.2006,24(7):1319-1320.
[38]杨辰华.从痰湿论治糖尿病胰岛素抵抗的体会[J].四川中医,2005,23(1):10-11.
[39]袁宪章.对糖尿病胰岛素抵抗从痰湿论治的认识[J].内蒙古中医药.2002,(5):24.
[40]王志程,刘铜华.从痰湿论治糖尿病[J].中国中医基础医学杂志.2007,13(8):601-602.
[41]孟晓嵘,吴秋英,吕绍光.糖尿病从痰湿论治研究概况[J].中医药学刊.2005,23(12):2239-2240.
[42]乔玉秋,王志同.从痰论治糖尿病体会[J].浙江中医杂志.2004,11(11):493-494.
[43]李美华.糖尿病从湿热论治浅析[J].陕西中医.2002,23(1):94-95.
[44]韩培海,徐海雁,唐长华等.李富玉教授从痰湿论治糖尿病[J].北京中医药大学学报(中医临床版).2007,14(3):36-37.
[45]杨超.从痰论治糖尿病并发症[J].现代养生.2006,(9):5.
[46]卞镝,李敬林,董天宝.从痰论治糖尿病肾病[J].辽宁中医杂志.2006,33(11):1404-1405.
[47]袁艳娟,王旭.糖尿病从瘀论治探讨[J].第九次全国中医糖尿病学术大会论文汇编.2006.275-278.
[48]张永杰.从瘀血论治消渴[J].河南中医学院学报.2007,22(131):10-11.
[49]赵云芳,刘景超.糖尿病从瘀论治体会[J].四川中医.2002,20(10):11-12.
[50]蒋俏兰.糖尿病从瘀论治[J].甘肃中医.2006,19(8):43.
[51]赵g勤.从瘀论治2型糖尿病38例临床观察[J].浙江中西医结合杂志.2006,16(6):357-358.
[52]李春亮,张明柱.从“瘀”论治2型糖尿病肾病机理及疗效观察[J].时珍国医国药.2007,18(7):1629-1630.
[53]方水林.从瘀论治糖尿病肾病[J].世界中西医结合杂志.2007,2(1):20.
[54]丁文君,沈明霞.从瘀论治糖尿病肾病六法[J].甘肃中医学院学报.2007,24(1):8-10.
[55]陈筱云,赵莉娟.从瘀论治糖尿病肾病[J].中国中医基础医学杂志.2002,8(7):53-54.
[56]韩永刚.论痰瘀同源同病[J].中医杂志.2008,49(5):477.
[57]张爱华,衡先培.痰瘀论治糖尿病血管并发症的研究进展[J].江西中医药.2007,38(297):67-69.
[58]鞠凤芝.从痰瘀论治2型糖尿病浅探[J].实用中医内科杂志.2005,19(1):22.
[59]吕光霞.糖尿病从痰瘀论治管窥[J].河南中医.2003,23(12):74-75.
[60]郑曙琴.从痰瘀互结论治糖尿病周围神经病变疗效观察[J].中医药学刊.2006,24(1):229.
[61]胡维来.从痰瘀论治糖尿病周围神经病变[J].中国民间疗法.2003,11(4):8-9.
[62]陈娟,韩永明,张六通等.从“毒”论消渴的病因病机[J].山西中医学院学报.2007,8(4):61-62.
[63]潘善余.从毒辨治糖尿病探析[J].中华中医药学刊.2007,25(1):38-39.
[64]王雪威,南红梅.南征教授从毒损肾络说论治消渴肾病经验[J].世界中西医结合杂志.2007,2(5):254-255.
[65]张萌,冯建华.糖尿病从“毒”论治[J].第十次全国中医糖尿病学术大会论文汇编.2007.227-231.
[66]王玉霞.从毒论治糖尿病肾病50例临床观察[J].中华实用中西医杂志.2004,4(17):1835-1836.
[67]吴茂林.从毒损络瘀论治糖尿病阳痿思路探析[J]中医研究.2007,20(5):9-10.
[68]陆付耳,王智明,郭爱群.糖尿病从“毒”论治探讨[J].中国中医基础医学杂志.2002,8(5):15-17.
[69]韩永刚,冯兴中.糖尿病“从气论治,心身并调”的探讨[J].北京中医药大学学报(中医临床版).2007,14(1):38-39.
[70]陈霞波,周开,龚文波.王晖从气论治糖尿病的经验[J].浙江中医杂志.2004,(8):328-329.
[71]杨辰华.刘完素玄府气液理沦与消渴病治疗思路[J].辽宁中医杂志.2006,33(9):1094-1095.
[72]王永炎.创新是中医学术发展的必然要求[J].山东中医药大学学报.2005,29(6):415-416.
[73]王永炎.读经典做临床是培养优秀中医临床人才的重要途径[J].辽宁中医杂志.2005,32(5):385-386.
[74]胡显宜,汪世平.《内经》开阖枢考辨[J].四川中医.2002,20(8):15-17.
[75]赵诗哲.论“少阳枢”、“少阴枢”的理论及其临床应用[J].浙江中医杂志.2006,41(3):125-127.
[76]刘力红.思考中医[M].广西:广西师范大学出版社.2003年12月第2版.79,107,144,227,324,328,423,439,467.
[77]卢崇汉.扶阳讲记[M].北京:中国中医药出版社.2006年第1版.
[78]任应秋.中医各家学说[M].上海:上海科学技术出版社.1986年第1版.
[79]梁华龙.六经开阖枢学说的渊源及应用[J].河南中医.1998,18(2):5,6,16.
[80]丰广魁.“枢机”探微[J]冲国中医药信息杂志.2006,13(7):6-7.
[81]张晓梅,肖培新.试论少阳在外感病中的枢机作用[J].北京中医药大学学报.2003,26(4):23-24.
[82]丰广魁.小柴胡汤透转枢机临证举隅[J].辽宁中医杂志.2005,32(11):1202-1203.
[83]张福华,于学美.浅谈“枢机”及其临床意义[J].山东中医药大学学报.2004,28(1):23-24.
[84]周尔文.少阳枢机与五脏[J].天津中医学院学报.1991,(2):35-36.
[85]林士毅.小柴胡汤“导引法”机理及临床应用研究[D].山东中医药大学2003级硕士研究生学位论文.
[86]李宇航.论四逆散丌阖以运枢机[J].北京中医药大学学报.1998,21(4):11-13.
[87]李心机.伤寒论疑难解读[M].北京.人民卫生出版社.1999.241-247.
[88]柯琴.伤寒来苏集[M].上海.上海科学技术出版社,1986.253,142.
[89]吴贵娥.小柴胡汤古代运用考探[D].北京中医药大学2002级硕士研究生学位论文.
[90]岩崎学(Iwazaki Gaku).小柴胡汤在日本的运用状况研究[D].北京中医药大学2003级硕士研究生学位论文.
[91]裴永清.伤寒论临床应用五十论[M].北京.学苑出版社.1995.87.
[92]孙星衍,孙冯翼.神农本草经[M].北京.科学技术文献出版社.1999.
[93]高飞.小柴胡汤证解析(二)[J].北京中医学院学报.1989,12(1):19-20.
[94]姜建国.伤寒思辨[M].山东.山东大学出版社.1995.67.
[95]尤怡.伤寒贯珠集[M].北京.中医古籍出版社.1998.128.
[96]周鸿艳.柴胡研究简史[D].黑龙江中医药大学2000级硕士研究生学位论文.18-21.
[97]南征,高彦彬,钱秋海.糖尿病中西医综合治疗[M].北京:人民卫生出版社,2002.
[98]王兰英.我国Ⅱ型糖尿病的流行病学及危险因素研究[J].中国医药导报.2007,12(4):4,11.
[99]柳剑,蓝绍颖.2型糖尿病危险因素的流行病学研究进展[J].南通大学学报(医学版).2006,26(3):230-232.
[100]刘玉秀,贾红,李爱玲等.2型糖尿病危险因素研究概况[J].预防医学情报杂志.2005,21(2):168-172.
[101]陶志阳,刘克俭.2型糖尿病患者行为心理的性别分布及其患病的危险因素分析[J].中国全科医学.2005,8(15):1242-1244.
[102]李建军.2型糖尿病及其相关因素的认识与评价[J].临沂医学专科学校学报.2005,27(5):353-354.
[103]魏军平,林兰.中西医结合治疗糖尿病经验与优势[J].世界中西医结合杂志.2006,1(6):316-319.
[104]刘尊永.糖尿病综合防治指南[M].北京:人民卫生出版社,2004.
[105]冯兴中,姜敏,卢苇等.糖尿病心身病证辨治初探[J].北京中医药大学学报.2003,26(2):68-70.
[106]郑筱萸.中药新药临床研究指导原则(试行)[M].中国医药科技出版社.2002.
[107]徐雁,耿兴斌.Ridit分析在临床治疗效果评价中的应用[J].数理医药学杂志.1995,8(3):259-260.
[108]蒋知俭.统计分析在医学课题中的应用[M].人民卫生出版社.2008.
[109]苏金平,王泽颖,陈景武.单组重复测量资料方差分析及趋势分析在中医辨证卒中单元研究中的应用[J].数理医药学杂志.2007,20(5):668-670.
[110]陈卓蕾,陈兴宝.重复测量统计分析方法在抑郁症患者生命质量研究中的应用[J].复旦学报(医学版).2007,34(3):396-399.
[111]李刘坤.吴鞠通医学全书[M].北京:中国中医药出版社,1999.
[112]湛垦华,沈小峰.普里高津与耗散结构理论[M].西安:陕西科学技术出版社,1982.
[113]杨喜山.从耗散结构理论谈临床医师的知识构建[J].中国医学理论和实 践.2003,3:266-267.
[114]郭蕾,王永炎.论中医证候中的复杂现象及相应的研究思路[J].中国中医基础医学杂志.2004,10(2):3-5.
[115]李芳,李建北,张东明.柴胡的药理研究进展[J].时珍国医国药.2004,15(2):120-121.
[116]周晓霞,苏佩清,刘智.黄芩茎叶总黄酮对糖尿病防治作用的实验研究[J].中药新药与临床药理.2006,17(6):418-420.
[117]董砚虎,钱薇薇.黄芩甙对糖尿病患者周围神经传导速度和尿微量白蛋白排泄的影响[J].中国中西医结合杂志.2002,22(12):915-917.
[118]张启荣,朱克刚,彭吉霞等.枳实煎剂对兔离体肠平滑肌活动的影响[J].中国中医药科技.2006,13(5):335-336.
[119]阮金兰,赵钟祥,曾庆忠等.赤芍化学成分和药理作用的研究进展[J].中国药理学通报.2003,19(9):965-970.
[120]张春梅.葛根素治疗2型糖尿病及其并发症的研究进展[J].黑龙江医学.2007,31(9):669-672.
[121]赵慧娟,罗贵军.葛根素治疗2型糖尿病的疗效观察[J].实用中西医结合临床.2005,5(1):23.
[122]黄庆仪,徐进华.葛根素对糖尿病周围神经病变的临床研究[J].中西医结合心脑血管病杂志.2005,3(5):387-388.
[123]陈频,徐向进.葛根素治疗2型糖尿病及对凝血纤溶活性和内皮功能的影响[J].中国误诊学杂志.2007,7(17):3849-3951.
[124]高斌,白淑英,杜文斌等.苍术降血糖作用的实验研究[J].中国中医药科技.1998,5(3):162.
[125]陈炎明,陈静,侴桂新.苍术化学成分和药理活性研究进展[J].上海中医药大学学报.2002,20(4):95-98.
[126]王小英,肖柳英,潘竞锵.甘草对抗D-半乳糖诱导大鼠糖尿病模型的实验研究[J].中国药业.2007,16(13):8-10.
[127]于辉,李春香,宫凌涛.甘草的药理作用概述[J].现代生物医学进展.2006,6(4):77-79.
[02]李学军.应用生活质量标准评估中西医结合疗法治疗糖尿病的效应[J].中国临床康复.2006,10(15):154,155,161.
[03]胡春宇.糖尿病与消渴病关系诠释及糖尿病辨治理念的探索[D].中国中医研究院2002级博士学位论文.15-23.
[04]张亚,王旭.2型糖尿病从肝论治机理探析[J].第九次全国中医糖尿病学术大会论文汇编.2006.272-274.
[05]林丽华,陈润东.从肝论治糖尿病的理论基础[J].中医药导报.2006,12(10):1,2,9.
[06]刘振杰,林国清.2型糖尿病从肝论治浅析[J].陕西中医.2005,26(12):1399-1400.
[07]段颖,刘铜华.从肝论治糖尿病的研究进展[J].第九次全国中医糖尿病学术大会论文汇编.2006.479-483.
[08]孟景,吴敏.糖尿病从肝论治依据回顾性探讨[J].实用中医内科杂志.2006,20(6):588-589.
[09]姜生坤,马新和,乔富渠.Ⅱ型糖尿病从肝论治探讨[J].陕西中医.2002,23(5):428-430.
[10]于淼,朴春丽,南征.2型糖尿病胰岛素抵抗从毒损肝络论治的理论初探[J].上海中医药杂志.2007,41(3):18-20.
[11]高绍芳,赵克景,杜立建等.浅谈糖尿病从肝论治[J].现代中西医结合杂志.2006,15(18):2512-2513.
[12]孟景,吴敏.糖尿病从肝论治依据回顾性探讨[J].实用中医内科杂志.2006,20(6):588-589.
[13]郭翔宇,刘铜华.消渴病从肝肿肾论治[J].第十次全国中医糖尿病学术大会论文汇编.2007.334-335.
[14]张凌志.试论糖尿病脾虚湿滞证[J].北京中医药大学学报.2002,25(3):71.
[15]李江慧.糖尿病证候统计分析[J].中国医药学报.1999,14(6):70.
[16]张超,张军,韦新宇.从脾论治糖尿病的研究近况[J].河南中医.2003,23(12):85-87.
[17]张春吉,吴铁.从脾论治消渴病体会[J].第九次全国中医糖尿病学术大会论文汇编.2006.282-284.
[18]贺文广,杨竞,钟丽红.杨竞从脾论治糖尿病的经验[J].上海中医药杂志.2005,39(3):27-28.
[19]孙鑫.从脾论治糖尿病[J].第十次全国中医糖尿病学术大会论文汇编.2007.142-147.
[20]朱汀,孙寒静.冯明清教授从脾论治糖尿病经验[J].四川中医.2002,20(4):3-4.
[21]韩洪刚.潘朝曦教授从脾论治糖尿病经验[J].实用中医内科杂志.2005,19(6):512-513.
[22]李士瑾,冯志海,徐立然等.浅谈从脾论治糖尿病[J].四川中医.2003,21(8):13-15.
[23]胡梅芳.糖尿病从脾论治分析[J].安徽中医临床杂志.2003,15(4):351-352.
[24]李肇晕,曲丽卿.再论脾与消渴病[J].时珍圉医圈药.2006,17(8):1557-1558.
[25]姬厚民.消渴病(糖尿病)从肾论治的内分泌学机制初探[J].北京中医.2007,26(5):286.
[26]蒋兆定,李灿华.糖尿病从心论治初探[J].辽宁中医学院学报.2004,6(2):98.
[27]蔡小平,周宜强,朱艳琴.糖尿病证治新理论--“脾弱胃强”观[J].中国中医基础医学杂志.2003,9(5):25-26.
[28]刘振杰,熊莉华,范冠杰.浅谈糖尿病从脾胃论治[J].新中医.2006,38(8):84-85.
[29]刘自力,吴兆利.从肝脾论治糖尿病[J].中医药信息.2005,22(6):31-34.
[30]刘振杰.糖尿病从肝脾胃论治浅析[J].江西中医药.2006,37(8):12-13.
[31]侯茗.从肺、脾(胃)、肾论治消渴病[J].中国社区中师.2007,9(2):53.
[32]接传红,陈晨,罗旭昇等.从心肾论治糖尿病视网膜病变[J].第十次全国中医糖尿病学术大会论文汇编.2007.427-428.
[33]米丰涛.从脾肾两虚论治老年性糖尿病32例[J].黑龙江中医药.2006,(2):31-23.
[34]安淑华.从脾肾论治老年性糖尿病的机理及疗效观察[J].河北北方学院学报(医学版).2007,24(4):59-60.
[35]高思华.以中西医结合理论为指导,立足肝脾肾辨治糖尿病[J].中国中西医结合杂志.1994,14(10):622-623.
[36]刘晓平.糖尿病从五脏辨治[J].中医药学刊.2005,23(10):1906-1907.
[37]王幸栓,欧晓燃,杜杏坤.五脏通治法联合胰岛素治疗初诊2型糖尿病的可行性探讨[J].中医药学刊.2006,24(7):1319-1320.
[38]杨辰华.从痰湿论治糖尿病胰岛素抵抗的体会[J].四川中医,2005,23(1):10-11.
[39]袁宪章.对糖尿病胰岛素抵抗从痰湿论治的认识[J].内蒙古中医药.2002,(5):24.
[40]王志程,刘铜华.从痰湿论治糖尿病[J].中国中医基础医学杂志.2007,13(8):601-602.
[41]孟晓嵘,吴秋英,吕绍光.糖尿病从痰湿论治研究概况[J].中医药学刊.2005,23(12):2239-2240.
[42]乔玉秋,王志同.从痰论治糖尿病体会[J].浙江中医杂志.2004,11(11):493-494.
[43]李美华.糖尿病从湿热论治浅析[J].陕西中医.2002,23(1):94-95.
[44]韩培海,徐海雁,唐长华等.李富玉教授从痰湿论治糖尿病[J].北京中医药大学学报(中医临床版).2007,14(3):36-37.
[45]杨超.从痰论治糖尿病并发症[J].现代养生.2006,(9):5.
[46]卞镝,李敬林,董天宝.从痰论治糖尿病肾病[J].辽宁中医杂志.2006,33(11):1404-1405.
[47]袁艳娟,王旭.糖尿病从瘀论治探讨[J].第九次全国中医糖尿病学术大会论文汇编.2006.275-278.
[48]张永杰.从瘀血论治消渴[J].河南中医学院学报.2007,22(131):10-11.
[49]赵云芳,刘景超.糖尿病从瘀论治体会[J].四川中医.2002,20(10):11-12.
[50]蒋俏兰.糖尿病从瘀论治[J].甘肃中医.2006,19(8):43.
[51]赵g勤.从瘀论治2型糖尿病38例临床观察[J].浙江中西医结合杂志.2006,16(6):357-358.
[52]李春亮,张明柱.从“瘀”论治2型糖尿病肾病机理及疗效观察[J].时珍国医国药.2007,18(7):1629-1630.
[53]方水林.从瘀论治糖尿病肾病[J].世界中西医结合杂志.2007,2(1):20.
[54]丁文君,沈明霞.从瘀论治糖尿病肾病六法[J].甘肃中医学院学报.2007,24(1):8-10.
[55]陈筱云,赵莉娟.从瘀论治糖尿病肾病[J].中国中医基础医学杂志.2002,8(7):53-54.
[56]韩永刚.论痰瘀同源同病[J].中医杂志.2008,49(5):477.
[57]张爱华,衡先培.痰瘀论治糖尿病血管并发症的研究进展[J].江西中医药.2007,38(297):67-69.
[58]鞠凤芝.从痰瘀论治2型糖尿病浅探[J].实用中医内科杂志.2005,19(1):22.
[59]吕光霞.糖尿病从痰瘀论治管窥[J].河南中医.2003,23(12):74-75.
[60]郑曙琴.从痰瘀互结论治糖尿病周围神经病变疗效观察[J].中医药学刊.2006,24(1):229.
[61]胡维来.从痰瘀论治糖尿病周围神经病变[J].中国民间疗法.2003,11(4):8-9.
[62]陈娟,韩永明,张六通等.从“毒”论消渴的病因病机[J].山西中医学院学报.2007,8(4):61-62.
[63]潘善余.从毒辨治糖尿病探析[J].中华中医药学刊.2007,25(1):38-39.
[64]王雪威,南红梅.南征教授从毒损肾络说论治消渴肾病经验[J].世界中西医结合杂志.2007,2(5):254-255.
[65]张萌,冯建华.糖尿病从“毒”论治[J].第十次全国中医糖尿病学术大会论文汇编.2007.227-231.
[66]王玉霞.从毒论治糖尿病肾病50例临床观察[J].中华实用中西医杂志.2004,4(17):1835-1836.
[67]吴茂林.从毒损络瘀论治糖尿病阳痿思路探析[J]中医研究.2007,20(5):9-10.
[68]陆付耳,王智明,郭爱群.糖尿病从“毒”论治探讨[J].中国中医基础医学杂志.2002,8(5):15-17.
[69]韩永刚,冯兴中.糖尿病“从气论治,心身并调”的探讨[J].北京中医药大学学报(中医临床版).2007,14(1):38-39.
[70]陈霞波,周开,龚文波.王晖从气论治糖尿病的经验[J].浙江中医杂志.2004,(8):328-329.
[71]杨辰华.刘完素玄府气液理沦与消渴病治疗思路[J].辽宁中医杂志.2006,33(9):1094-1095.
[72]王永炎.创新是中医学术发展的必然要求[J].山东中医药大学学报.2005,29(6):415-416.
[73]王永炎.读经典做临床是培养优秀中医临床人才的重要途径[J].辽宁中医杂志.2005,32(5):385-386.
[74]胡显宜,汪世平.《内经》开阖枢考辨[J].四川中医.2002,20(8):15-17.
[75]赵诗哲.论“少阳枢”、“少阴枢”的理论及其临床应用[J].浙江中医杂志.2006,41(3):125-127.
[76]刘力红.思考中医[M].广西:广西师范大学出版社.2003年12月第2版.79,107,144,227,324,328,423,439,467.
[77]卢崇汉.扶阳讲记[M].北京:中国中医药出版社.2006年第1版.
[78]任应秋.中医各家学说[M].上海:上海科学技术出版社.1986年第1版.
[79]梁华龙.六经开阖枢学说的渊源及应用[J].河南中医.1998,18(2):5,6,16.
[80]丰广魁.“枢机”探微[J]冲国中医药信息杂志.2006,13(7):6-7.
[81]张晓梅,肖培新.试论少阳在外感病中的枢机作用[J].北京中医药大学学报.2003,26(4):23-24.
[82]丰广魁.小柴胡汤透转枢机临证举隅[J].辽宁中医杂志.2005,32(11):1202-1203.
[83]张福华,于学美.浅谈“枢机”及其临床意义[J].山东中医药大学学报.2004,28(1):23-24.
[84]周尔文.少阳枢机与五脏[J].天津中医学院学报.1991,(2):35-36.
[85]林士毅.小柴胡汤“导引法”机理及临床应用研究[D].山东中医药大学2003级硕士研究生学位论文.
[86]李宇航.论四逆散丌阖以运枢机[J].北京中医药大学学报.1998,21(4):11-13.
[87]李心机.伤寒论疑难解读[M].北京.人民卫生出版社.1999.241-247.
[88]柯琴.伤寒来苏集[M].上海.上海科学技术出版社,1986.253,142.
[89]吴贵娥.小柴胡汤古代运用考探[D].北京中医药大学2002级硕士研究生学位论文.
[90]岩崎学(Iwazaki Gaku).小柴胡汤在日本的运用状况研究[D].北京中医药大学2003级硕士研究生学位论文.
[91]裴永清.伤寒论临床应用五十论[M].北京.学苑出版社.1995.87.
[92]孙星衍,孙冯翼.神农本草经[M].北京.科学技术文献出版社.1999.
[93]高飞.小柴胡汤证解析(二)[J].北京中医学院学报.1989,12(1):19-20.
[94]姜建国.伤寒思辨[M].山东.山东大学出版社.1995.67.
[95]尤怡.伤寒贯珠集[M].北京.中医古籍出版社.1998.128.
[96]周鸿艳.柴胡研究简史[D].黑龙江中医药大学2000级硕士研究生学位论文.18-21.
[97]南征,高彦彬,钱秋海.糖尿病中西医综合治疗[M].北京:人民卫生出版社,2002.
[98]王兰英.我国Ⅱ型糖尿病的流行病学及危险因素研究[J].中国医药导报.2007,12(4):4,11.
[99]柳剑,蓝绍颖.2型糖尿病危险因素的流行病学研究进展[J].南通大学学报(医学版).2006,26(3):230-232.
[100]刘玉秀,贾红,李爱玲等.2型糖尿病危险因素研究概况[J].预防医学情报杂志.2005,21(2):168-172.
[101]陶志阳,刘克俭.2型糖尿病患者行为心理的性别分布及其患病的危险因素分析[J].中国全科医学.2005,8(15):1242-1244.
[102]李建军.2型糖尿病及其相关因素的认识与评价[J].临沂医学专科学校学报.2005,27(5):353-354.
[103]魏军平,林兰.中西医结合治疗糖尿病经验与优势[J].世界中西医结合杂志.2006,1(6):316-319.
[104]刘尊永.糖尿病综合防治指南[M].北京:人民卫生出版社,2004.
[105]冯兴中,姜敏,卢苇等.糖尿病心身病证辨治初探[J].北京中医药大学学报.2003,26(2):68-70.
[106]郑筱萸.中药新药临床研究指导原则(试行)[M].中国医药科技出版社.2002.
[107]徐雁,耿兴斌.Ridit分析在临床治疗效果评价中的应用[J].数理医药学杂志.1995,8(3):259-260.
[108]蒋知俭.统计分析在医学课题中的应用[M].人民卫生出版社.2008.
[109]苏金平,王泽颖,陈景武.单组重复测量资料方差分析及趋势分析在中医辨证卒中单元研究中的应用[J].数理医药学杂志.2007,20(5):668-670.
[110]陈卓蕾,陈兴宝.重复测量统计分析方法在抑郁症患者生命质量研究中的应用[J].复旦学报(医学版).2007,34(3):396-399.
[111]李刘坤.吴鞠通医学全书[M].北京:中国中医药出版社,1999.
[112]湛垦华,沈小峰.普里高津与耗散结构理论[M].西安:陕西科学技术出版社,1982.
[113]杨喜山.从耗散结构理论谈临床医师的知识构建[J].中国医学理论和实 践.2003,3:266-267.
[114]郭蕾,王永炎.论中医证候中的复杂现象及相应的研究思路[J].中国中医基础医学杂志.2004,10(2):3-5.
[115]李芳,李建北,张东明.柴胡的药理研究进展[J].时珍国医国药.2004,15(2):120-121.
[116]周晓霞,苏佩清,刘智.黄芩茎叶总黄酮对糖尿病防治作用的实验研究[J].中药新药与临床药理.2006,17(6):418-420.
[117]董砚虎,钱薇薇.黄芩甙对糖尿病患者周围神经传导速度和尿微量白蛋白排泄的影响[J].中国中西医结合杂志.2002,22(12):915-917.
[118]张启荣,朱克刚,彭吉霞等.枳实煎剂对兔离体肠平滑肌活动的影响[J].中国中医药科技.2006,13(5):335-336.
[119]阮金兰,赵钟祥,曾庆忠等.赤芍化学成分和药理作用的研究进展[J].中国药理学通报.2003,19(9):965-970.
[120]张春梅.葛根素治疗2型糖尿病及其并发症的研究进展[J].黑龙江医学.2007,31(9):669-672.
[121]赵慧娟,罗贵军.葛根素治疗2型糖尿病的疗效观察[J].实用中西医结合临床.2005,5(1):23.
[122]黄庆仪,徐进华.葛根素对糖尿病周围神经病变的临床研究[J].中西医结合心脑血管病杂志.2005,3(5):387-388.
[123]陈频,徐向进.葛根素治疗2型糖尿病及对凝血纤溶活性和内皮功能的影响[J].中国误诊学杂志.2007,7(17):3849-3951.
[124]高斌,白淑英,杜文斌等.苍术降血糖作用的实验研究[J].中国中医药科技.1998,5(3):162.
[125]陈炎明,陈静,侴桂新.苍术化学成分和药理活性研究进展[J].上海中医药大学学报.2002,20(4):95-98.
[126]王小英,肖柳英,潘竞锵.甘草对抗D-半乳糖诱导大鼠糖尿病模型的实验研究[J].中国药业.2007,16(13):8-10.
[127]于辉,李春香,宫凌涛.甘草的药理作用概述[J].现代生物医学进展.2006,6(4):77-79.